AIFM2 and central nervous system cancer: Additionally, the expression of GCH1 and FSP1 increased with increasing malignancy of the tumor (Figure 1E); GPX4, FSP1, and GCH1 were highly expressed in patients with glioma and wild-type IDH1 compared to mutant IDH1 (Figure 1F).